About: antimony(5+) cation

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: antimony(5+) cation Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

cation

Attributes	Values
rdf:type	Item
description	cation (en) kation (pl)
rdfs:label	antimona(V) katjono (eo) antimony(5+) cation (en) kation antymonu(5+) (pl)
skos:prefLabel	antimona(V) katjono (eo) antimony(5+) cation (en) kation antymonu(5+) (pl)
name	antimona(V) katjono (eo) antimony(5+) cation (en) kation antymonu(5+) (pl)
instance of	wds:Q27269467-3026DABB-1DFF-4428-BC51-9029F5FF5C03
instance of	type of chemical entity
subclass of	wds:Q27269467-47A635B0-1F6D-4CBF-BD0D-307374F5AC05 wds:Q27269467-6D48EC3D-2A18-4E37-AC32-32BDD17138FC
subclass of	monoatomic cation pentacation
UniChem compound ID	wds:Q27269467-FD1FD2A9-6A24-439C-9824-679ACDD0AAA7
Probes And Drugs ID	wds:Q27269467-9D2723BA-E2E1-49BA-AFC0-F77A9ED8E137
CAS Registry Number	wds:Q27269467-BBD8884A-E12A-49ED-B455-B1A1C4A97B7E
canonical SMILES	wds:Q27269467-912338B0-7AC2-4B5C-8C5E-69C9F93FD256
InChI	wds:Q27269467-98F523D6-9085-441C-923A-FE41B5F473B2
InChIKey	wds:Q27269467-09516EEF-1C53-4A2A-B6A7-DE3CA8F3D7AD
chemical formula	wds:Q27269467-EC76BFF2-FEA2-4F63-B310-572BA04D30DA
DSSTox substance ID	wds:Q27269467-7F5F7A6E-0629-4D87-90FA-413B79E020E5
RxNorm ID	wds:Q27269467-5D512C4A-5321-4EAC-914D-9B1C36EFA018
UNII	wds:Q27269467-A9FEA64C-CDDC-4E3F-ABA2-A47B1E2838C0
ChemSpider ID	wds:Q27269467-806CC042-4878-40C8-AF32-7CEDD0E66027
PubChem CID	wds:Q27269467-40B2CB5F-3DC3-42FC-8509-B6A50C5EADC4
DrugBank ID	wds:Q27269467-B2E2163F-38F5-411E-B736-106D7D6AE566
DSSTOX compound identifier	wds:Q27269467-B309C15C-1913-44AD-87BE-6690F66E13B6
ChemSpider ID	http://rdf.chemspider.com/10686455
PubChem CID	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73608879
UniChem compound ID	27306540
Probes And Drugs ID	PD058281
CAS Registry Number	22537-51-5
canonical SMILES	[Sb+5]
InChI	InChI=1S/Sb/q+5
InChIKey	ZDINGUUTWDGGFF-UHFFFAOYSA-N
chemical formula	Sb⁵⁺
DSSTox substance ID	DTXSID50872431
RxNorm ID	1546283
UNII	841L03HG64
ChemSpider ID	10686455
PubChem CID	73608879
DrugBank ID	13047
DSSTOX compound identifier	DTXCID30820071
skos:altLabel	SB5+ (en) antymon(5+) (pl) pentavalent antimony (en)
mass	wds:Q27269467-F230CE25-F079-4A5D-8838-838A69E456B4
mass	120.904 (xsd:decimal)
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q27269467
is main subject of	Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral Leishmaniasis First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony Reduction of pentavalent antimony by trypanothione and formation of a binary and ternary complex of antimony(III) and trypanothione. Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action Interleukin 10 receptor blockade--pentavalent antimony treatment in experimental visceral leishmaniasis Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds? Response to interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis Leishmania major LmACR2 is a pentavalent antimony reductase that confers sensitivity to the drug pentostam. Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes. Glutathione-induced conversion of pentavalent antimony to trivalent antimony in meglumine antimoniate Rapid reduction of pentavalent antimony by trypanothione: potential relevance to antimonial activation Renal clearance of pentavalent antimony (sodium stibogluconate) Predictors of an unsatisfactory response to pentavalent antimony in the treatment of American visceral leishmaniasis Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro [Renal function in patients with mucocutaneous leishmaniasis treated with pentavalent antimony compounds] Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony Subacute toxicity of pentavalent antimony compounds in rats Immunochemotherapy of visceral leishmaniasis: a pilot trial of sequential treatment with recombinant interferon-gamma and pentavalent antimony Efficacy of pentavalent antimony, amphotericin B, and miltefosine in Leishmania amazonensis-infected macrophages under normoxic and hypoxic conditions Short report: efficacy of pentavalent antimony for treatment of colombian cutaneous leishmaniasis. Pentavalent antimony-mannan conjugate therapy of experimental visceral leishmaniasis Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony Visceral leishmaniasis in patients with AIDS: report of three cases treated with pentavalent antimony and interferon-gamma In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate In vivo and in vitro effects of pentavalent antimony on mouse liver cytochrome P450s. Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate) In vitro activity of pentavalent antimony derivatives on promastigotes and intracellular amastigotes of Leishmania infantum strains from humans and dogs in Spain Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp. from patients unresponsive to pentavalent antimony therapy. Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis Conduction defect following pentavalent antimony therapy in visceral leishmaniasis Different adsorption behaviors and mechanisms of a novel amino-functionalized hydrothermal biochar for hexavalent chromium and pentavalent antimony Sensitivity of Leishmania viannia panamensis to pentavalent antimony is correlated with the formation of cleavable DNA-protein complexes Short term treatment of visceral leishmaniasis of the Old World with low dose interferon gamma and pentavalent antimony A comparative controlled trial of intralesionally-administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis Intralesional therapy of American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil--an area of Leishmania (V.) braziliensis transmission The synergistic action of pyrazolopyrimidines and pentavalent antimony against Leishmania donovani and L. braziliensis Liposomal amphotericin B versus pentavalent antimony salts for visceral Leishmania in children Pharmacokinetics of pentavalent antimony (Pentostam) in hamsters Safety and efficacy of Miltefosine monotherapy and Pentoxifylline associated with Pentavalent Antimony in treating Mucosal Leishmaniasis. Polymorphism and properties of Bi2WO6 doped with pentavalent antimony [Effectiveness of aminosidine sulphate in severe visceral leishmaniasis, resistant to the treatment with pentavalent antimony] Oral Pentoxifylline Associated with Pentavalent Antimony: A Randomized Trial for Cutaneous Leishmaniasis. Oral pentoxifylline and pentavalent antimony for treatment of leishmaniasis: promising but inconclusive evidence of superiority, compared with antimony monotherapy

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software